Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Kirchhofer

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Molecular Oncology|October 24, 2023
Hepsin promotes breast tumor growth signaling via the TGFβ-EGFR axisDenis Belitškin, Pauliina Munne, Shishir M Pant, et al.
JCI Insight|August 5, 2016
Protective and detrimental effects of neuroectodermal cell-derived tissue factor in mouse models of strokeShaobin Wang, Brandi Reeves, Erica M Sparkenbaugh, et al.
Journal of the American Society of Nephrology : JASN|August 9, 2020
Domain-Specific Antibodies Reveal Differences in the Membrane Topologies of Apolipoprotein L1 in Serum and PodocytesNidhi Gupta, Xinhua Wang, Xiaohui Wen, et al.
Cancer Research|October 22, 2009
Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasisWei Li, Bu-Er Wang, Paul Moran, et al.
The FEBS Journal|January 17, 2020
Proprotein convertase 7 (PCSK7) reduces apoA-V levelsYahya Ashraf, Stéphanie Duval, Vatsal Sachan, et al.
The Journal of Biological Chemistry|November 15, 2013
Identification of a small peptide that inhibits PCSK9 protein binding to the low density lipoprotein receptorYingnan Zhang, Charles Eigenbrot, Lijuan Zhou, et al.
Disease Models & Mechanisms|August 20, 2025
HTRA1-dependent proteolysis induces age-related retinal degeneration and exacerbates choroidal neovascularizationKenneth J Katschke, Tom Truong, Victoria Pham, et al.
Journal of Molecular Biology|June 26, 2012
Calcium-independent inhibition of PCSK9 by affinity-improved variants of the LDL receptor EGF(A) domainYingnan Zhang, Lijuan Zhou, Monica Kong-Beltran, et al.
Clinical Cardiology|March 23, 2017
A phase 1 study to evaluate the safety and LDL cholesterol-lowering effects of RG7652, a fully human monoclonal antibody against proprotein convertase subtilisin/kexin type 9Amos Baruch, Diana Luca, Robert S Kahn, et al.
The Biochemical Journal|September 20, 2015
The trimeric serine protease HtrA1 forms a cage-like inhibition complex with an anti-HtrA1 antibodyClaudio Ciferri, Michael T Lipari, Wei-Ching Liang, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Molecular Oncology|October 24, 2023
Hepsin promotes breast tumor growth signaling via the TGFβ-EGFR axisDenis Belitškin, Pauliina Munne, Shishir M Pant, et al.
JCI Insight|August 5, 2016
Protective and detrimental effects of neuroectodermal cell-derived tissue factor in mouse models of strokeShaobin Wang, Brandi Reeves, Erica M Sparkenbaugh, et al.
Journal of the American Society of Nephrology : JASN|August 9, 2020
Domain-Specific Antibodies Reveal Differences in the Membrane Topologies of Apolipoprotein L1 in Serum and PodocytesNidhi Gupta, Xinhua Wang, Xiaohui Wen, et al.
Cancer Research|October 22, 2009
Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasisWei Li, Bu-Er Wang, Paul Moran, et al.
The FEBS Journal|January 17, 2020
Proprotein convertase 7 (PCSK7) reduces apoA-V levelsYahya Ashraf, Stéphanie Duval, Vatsal Sachan, et al.
The Journal of Biological Chemistry|November 15, 2013
Identification of a small peptide that inhibits PCSK9 protein binding to the low density lipoprotein receptorYingnan Zhang, Charles Eigenbrot, Lijuan Zhou, et al.
Disease Models & Mechanisms|August 20, 2025
HTRA1-dependent proteolysis induces age-related retinal degeneration and exacerbates choroidal neovascularizationKenneth J Katschke, Tom Truong, Victoria Pham, et al.
Journal of Molecular Biology|June 26, 2012
Calcium-independent inhibition of PCSK9 by affinity-improved variants of the LDL receptor EGF(A) domainYingnan Zhang, Lijuan Zhou, Monica Kong-Beltran, et al.
Clinical Cardiology|March 23, 2017
A phase 1 study to evaluate the safety and LDL cholesterol-lowering effects of RG7652, a fully human monoclonal antibody against proprotein convertase subtilisin/kexin type 9Amos Baruch, Diana Luca, Robert S Kahn, et al.
The Biochemical Journal|September 20, 2015
The trimeric serine protease HtrA1 forms a cage-like inhibition complex with an anti-HtrA1 antibodyClaudio Ciferri, Michael T Lipari, Wei-Ching Liang, et al.
Pageof 10